Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × Immunotherapy, Adoptive × Clear all

NCT06429150 2024-06-10

Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma

Phase 1/2 Recruiting

Multiple Myeloma, Plasmacytoma

NCT05521802 2023-03-24

A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Recruiting

Multiple Myeloma

NCT04097301 2022-01-19

Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma

Phase 1/2 Terminated

8 enrolled 13 charts

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, Myeloid, Acute

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Phase 1/2 Unknown

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT03271632 2019-09-19

Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma

Phase 1/2 Unknown

Multiple Myeloma

NCT01886976 2016-01-28

CART-138

Phase 1/2 Unknown

Multiple Myeloma